参考文献/References:
[1] JIN Y J,YU D,TIAN X L,et al.A novel and effective approach to generate germLine-like monoclonal antibodies by integration of phage and mammalian cell display platforms[J].Acta Pharmacol Sin,2022,43(4):954-962
[2] 郎巧利,余琳,何麒麟,等.高效构建卵清白蛋白scFv噬菌体文库及其筛选[J].中国生物工程杂志,2018,38(11):25-31.
LIANG Q L,YU L,HE Q L,et al.Construction and screening of a phage display library of single chain Fv antibody efficiently from mouse immunized with ovalbumin[J].Chin Biotechnol,2018,38(11):25-31.
[3] BAURAND P E,BALLAND J,REYNAS C,et al.Development of anti-LRRC15 small fragments for imaging purposes using a phage-display ScFv approach[J].Int J Mol Sci,2022,23(20):12677.
[4] DU J,XIANG D,LIU F,et al.Hijacking the self-replicating machine of bacteriophage for PCR-based cascade signal amplification in detecting SARS-CoV-2 viral marker protein in serum[J]. Sens Actuators B Chem,2023,374:132780.
[5] PEISSERT F,PLSS L,GIUDICE A M,et al.Selection of a PD-1 blocking antibody from a novel fully human phage display library[J].Protein Sci,2022,31(12):e4486.
[6] TAKAKUSAGI Y,TAKAKUSAGI K,SAKAGUCHI K,et al.Phage display technology for target determination of small-molecule therapeutics:an update[J].Expert Opin Drug Discov,2020,15(10):1199-1211.
[7] MENDOZA-SALAZAR I,GMEZ-CASTELLANO K M,GONZ-LEZ-GONZLEZ E,et al.Anti-SARS-CoV-2 Omicron antibodies isolated from a SARS-CoV-2 delta semi-immune phage display library[J].Antibodies,2022,11(1):13.
[8] 陈婷,贾秋蕾,褚瑜光,等.盐敏感性高血压收缩压负荷与肾素-血管紧张素-醛固酮系统、皮质醇相关性研究[J].中国循证心血管医学杂志,2022,14(1):84-86.
CHEN T,JIA Q L,CHU Y G,et al.Correlation among systolic blood pressure load,renin-angiotensin-aldosterone system and cortisol in patients with salt-sensitive hypertensive[J].Chin J Evid Based Cardiovasc Med,2022,14(1):84-86.
[9] COLUSSI G,CATENA C,LAPENNA R,et al.Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients[J].Diabetes Care,2007,30(9):2349-2354.
[10] 张念荣,李文歌.糖尿病患者高血压的治疗[J].中国临床医生杂志,2021,49(12):1399-1402.
ZHANG N R,LI W G.Treatment of hypertension in diabetic patients[J].Chin J Clin,2021,49(12):1399-1402.
[11] MORIMOTO R,OMATA K,ITO S,et al.Progress in the management of primary aldosteronism[J].Am J Hypertens,2018,31(5):522-531.
[12] VAN KLEEF M E A M,VISSEREN F L J,WESTERINK J,et al.Development of a clinical decision tool to reduce diagnostic testing for primary aldosteronism in patients with difficult-to-control hypertension[J].BMC Endocr Disord,2020,20(1):56.
[13] CHEN F,CHENG Z,PENG Y,et al.A liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based assay for simultaneous quantification of aldosterone,renin activity,and angiotensin II in human plasma[J].J Chromatogr B Analyt Technol Biomed Life Sci,2021,1179:122740.
[14] SHIDLOVSKYI V O,SHIDLOVSKYI O V,TOVKAI O A,et al.Topical diagnosis and determination of the primary hyperaldosteronism variant[J].J Med Life,2019,12(4):322-328.
[15] WANNACHALEE T,TURCU A F.Primary aldosteronism:a continuum from normotension to hypertension[J].Curr Cardiol Rep,2021,23(8):105.
[16] 赖凤华,曹筱佩,林慧美,等.两种血浆肾素、醛固酮检测方法对原发性醛固酮增多症筛查效率的评价[J].中华高血压杂志,2015,23(2):150-153.
LAI F H,CAO X P,LIN H M,et al.Comparison of plasma renin and aldosterone measured by radioimmunoassay and chemiluminescence immunoassay in screening primary aldosteronism[J].Chin J Hypertens,2015,23(2):150-153.
[17] PILZ S,KEPPEL M H,TRUMMER C,et al.Diagnostic accuracy of the aldosterone-to-active renin ratio for detecting primary aldosteronism[J].J Endocr Soc,2019,3(9):1748-1758.
[18] 李亚楠,张赛春,臧丽,等.甲状旁腺激素水平在原发性醛固酮增多症及肾上腺无功能瘤患者鉴别诊断中的应用价值[J].解放军医学院学报,2021,42(9):913-917.
LI Y N,ZHANG S C,ZANG L,et al.Value of parathyroid hormone level in differential diagnosis of patients with primary aldosteronism and nonfunctional adrenal tumors[J].Acad J Chin PLA Med Sch,2021,42(9):913-917.
[19] YANAI K,ISHIBASHI K,MORISHITA Y.Systematic review and meta-analysis of renin-angiotensin-aldosterone system blocker effects on the development of cardiovascular disease in patients with chronic kidney disease[J].Front Pharmacol,2021,12:662544.
[20] WANG Y,LI C X,LIN Y N,et al.The role of aldosterone in OSA and OSA-related hypertension[J].Front Endocrinol,2021,12:801689.
[21] WANG P,LUO C,ZHU D,et al.Pericardial adipose tissue-derived leptin promotes myocardial apoptosis in high-fat diet-induced obese rats through Janus kinase 2/reactive oxygen species/Na+/K+-ATPase signaling pathway[J].J Am Heart Assoc,2021,10(18):e021369.
[22] BOTHOU C,BEUSCHLEIN F,SPYROGLOU A.Links between aldosterone excess and metabolic complications:a comprehensive review[J].Diabetes Metab,2020,46(1):1-7.
[23] STEWART COATS A J,SHEWAN L.Eplerenone′s role in the management of complex cardiovascular disorders[J].Int J Cardiol,2015,200:1-2.
[24] KALIL G Z,HAYNES W G.Sympathetic nervous system in obesity-related hypertension:mechanisms and clinical implications[J].Hypertens Res,2012,35(1):4-16.
[25] LIN X,ULLAH M H E,WU X,et al.Cerebro-cardiovascular risk,target organ damage,and treatment outcomes in primary aldosteronism[J].Front Cardiovasc Med,2021,8:798364.
[26] TOMILIN V N,PYRSHEV K,KHAYYAT N H,et al.With-No-lysine kinase 1 (WNK1) augments TRPV4 function in the aldosterone-sensitive distal nephron[J].Cells,2021,10(6):1482.
[27] JONES J C,CARTER G D,MACGREGOR G A.Interference by polar metabolites in a direct radioimmunoassay for plasma aldosterone[J].Ann Clin Biochem,1981,18(Pt 1):54-59.